Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway by Meng Zhu, Yingli Han, Tianning Gu, Rui Wang, Xiaohui Si, Delin Kong, Peng Zhao, Xiujian Wang, Jinxin Li, Xingyuan Zhai, Zebin Yu, Huan Lu, Jingyi Li, He Huang, Pengxu Qian

Get full text